# Evaluation of Cyberknife Precision Radiation Delivery System for Unresectable Malignant Lung Cancer

> **NCT00238602** · PHASE1,PHASE2 · COMPLETED · sponsor: **Stanford University** · enrollment: 48 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **PROCEDURE:** Stereotactic radiosurgery

## Key facts

- **NCT ID:** NCT00238602
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-03
- **Primary completion:** 2007-06
- **Final completion:** 2012-06
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2012-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00238602

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00238602, "Evaluation of Cyberknife Precision Radiation Delivery System for Unresectable Malignant Lung Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00238602. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*